Italia markets closed

CMPS May 2024 7.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,3600+0,2600 (+23,64%)
In data: 11:10AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,1000
Aperto1,5500
Denaro1,2000
Lettera1,4500
Prezzo d'esercizio7,50
Scadenza2024-05-17
Min-Max giorno1,3600 - 1,9000
Contratto - Min-MaxN/D
Volume6
Open Interest161
  • GlobeNewswire

    COMPASS Pathways appoints Daphne Karydas to its Board of Directors

    LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Daphne Karydas to its Board of Directors, effective September 18, 2023. Ms. Karydas is President and Chief Financial Officer at Flare Therapeutics Inc., a privately held biotechnology company targeting transcription factors to discover precision medicines for c

  • GlobeNewswire

    COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

    LONDON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a new paper in Pyschopharmacology, which showed the results of a retrospective study that evaluates the potential of its AI technologies to support investigational COMP360 psilocybin treatment in treatment-resistant depression (TRD). The paper was published on

  • GlobeNewswire

    COMPASS Pathways to participate in upcoming September investor conferences

    LONDON, Aug. 29, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following investor conferences: Citi’s 18th Annual BioPharma Conference: host investor meetings on September 7, 2023HC Wainwright 25th Annual Global Investment Conference: fireside chat at 3:30pm on September 11, 2023 and host investor meetingsMorgan St